Insider: Mainolfi Nello Chief Executive Officer - Kymera Therapeutics, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 660,482 | 0 | 660,482 |
| Value | $36,300,090.72 | $0.00 | $36,300,090.72 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 09/16/2025 | DDS | 30,000 | Direct | COM | $49.00 | $1,470,000.00 | 660,482 |
| 06/03/2025 | DDS | 30,000 | Direct | COM | $49.00 | $1,470,000.00 | 660,482 |
| 01/12/2022 | DDS | 4,022 | Direct | COM | $52.02 | $209,209.56 | 474,063 |
| 01/12/2022 | DDS | 2,726 | Direct | COM | $51.31 | $139,877.06 | 478,085 |
| 01/12/2022 | DDS | 1,623 | Direct | COM | $53.27 | $86,457.21 | 472,440 |
| 01/12/2022 | DDS | 241 | Direct | COM | $53.97 | $13,006.77 | 472,199 |
| 01/11/2022 | DDS | 9,932 | Direct | COM | $53.68 | $533,109.04 | 479,190 |
| 01/11/2022 | DDS | 6,644 | Direct | COM | $54.42 | $361,582.43 | 472,546 |
| 01/11/2022 | DDS | 347 | Direct | COM | $55.05 | $19,103.36 | 472,199 |
| 01/10/2022 | DDS | 10,673 | Direct | COM | $53.35 | $569,378.93 | 476,506 |
| 01/10/2022 | DDS | 7,485 | Direct | COM | $52.46 | $392,643.64 | 487,179 |
| 01/10/2022 | DDS | 4,201 | Direct | COM | $54.40 | $228,545.32 | 472,305 |
| 01/10/2022 | DDS | 106 | Direct | COM | $54.99 | $5,828.94 | 472,199 |
| 10/11/2021 | DDS | 5,712 | Direct | COM | $53.58 | $306,043.82 | 464,943 |
| 10/11/2021 | DDS | 744 | Direct | COM | $54.50 | $40,546.44 | 464,199 |
| 10/08/2021 | DDS | 9,369 | Direct | COM | $56.82 | $532,390.61 | 475,138 |
| 10/08/2021 | DDS | 21,236 | Direct | COM | $55.56 | $1,179,867.91 | 484,507 |
| 10/08/2021 | DDS | 2,078 | Direct | COM | $57.29 | $119,045.92 | 473,060 |
| 10/08/2021 | DDS | 670 | Direct | COM | $60.32 | $40,412.06 | 464,470 |
| 10/08/2021 | DDS | 7,920 | Direct | COM | $59.28 | $469,462.75 | 465,140 |
| 10/08/2021 | DDS | 271 | Direct | COM | $61.87 | $16,766.77 | 464,199 |
| 08/04/2021 | DDS | 1,037 | Direct | COM | $60.03 | $62,252.87 | 452,199 |
| 08/03/2021 | DDS | 5,669 | Direct | COM | $60.07 | $340,533.43 | 452,199 |
| 08/02/2021 | DDS | 21,632 | Direct | COM | $60.21 | $1,302,354.56 | 454,023 |
| 08/02/2021 | DDS | 1,524 | Direct | COM | $61.28 | $93,386.61 | 452,499 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research